Profileimage by Joseph Gut Consultant, Medical & Scientific Writer, Pharmacovigilance, Drug Safety from SaintLouis

Joseph Gut

available

Last update: 09.11.2022

Consultant, Medical & Scientific Writer, Pharmacovigilance, Drug Safety

Graduation: Ph.D.
Hourly-/Daily rates: show
Languages: German (Native or Bilingual) | English (Limited professional) | French (Limited professional)

Keywords

Pharmacovigilance Genetics Medical Writing

Attachments

jg-cv-newest-2022-november.pdf

Skills

Genetics in Human Drug Safety, Pharmacovigilance, Regulatory, Scientific & Medical Writing, Preparation of Registration Document acc. ICH- and REACH- Guidelines, Writing and Bloging towards Patient- and General-Public.

Project history

11/2011 - 11/2015
Preclinical Assessor / Le ad GLP-Inspector
Swissmedic: Agency for Therapeutic Products

* Delivered quality assessments of studies.
* Completed preclinical and clinical drug safety assessments, identifying and analysing risks, assessing FIM
preclinical safety dossiers.
* Undertook GLP-inspections and devised associated reports, adhering to ICH-guidelines and regulations on
GLP, GMP, GCP and GVP.
* Led Pharmaco and toxicogenetic predispositions of subpopulations and single individuals for drug-induced
disease and serious ADRs.

01/2005 - 12/2011
Founder & Senior Consultant
Theragenomics Associates (TGA)

* Established company, a glocalized interactive social network and knowledge base, specialising in
theragenomic, personalized medicine and individualized drug safety.
* Wrote 900+ blog posts to support activities, covering topics of theragenomics, personalized medicine, and
individualized drug safety, posted in English, French and German languages to reach a global audience
(www.thasso.com ).
* Individualized drug safety and personalized medicine - University of Basel.

01/2000 - 01/2005
CEO/CSO
TheraSTrat AG

* Identified underlying mechanisms and pathways, leading to drug-induced disease and ADRs.
* Delivered evidence-based prediction of ADRs in subpopulations and single patients.
* Studied drug-metabolism, drug-drug interactions and the influence of endogenous, dietary, environmental,
occupational and behavioural compounds on drug-induced disease.
* Provided prediction of in vitro and in vivo correlations in molecular animal and human toxicology.
* and in drug disposition.
* Oversaw drug safety related knowledge ontologies and knowledge management systems.
* Built and developed strong global customer relations.
* Presented complex scientific and business topics.

01/1995 - 01/2000
Group Leader
Novartis Pharma


Local Availability

Open to travel worldwide
Remote bevorzugt.
2 Tage pro Woche vor Ort angenehm.
Profileimage by Joseph Gut Consultant, Medical & Scientific Writer, Pharmacovigilance, Drug Safety from SaintLouis Consultant, Medical & Scientific Writer, Pharmacovigilance, Drug Safety
Register